Literature DB >> 32931685

Association of Lung Function With HIV-Related Quality of Life and Health Care Utilization in a High-Risk Cohort.

Sarath Raju1, Meredith C McCormack1, Michael Bradley Drummond2, Hema C Ramamurthi3, Christian A Merlo1, Robert A Wise1, Shruti H Mehta3, Robert H Brown3, Gregory D Kirk1,3.   

Abstract

BACKGROUND: Chronic respiratory disease represents an important comorbidity for persons living with HIV (PLWH). HIV itself is associated with greater impairment in lung function. We aimed to determine the association between declining lung function and both quality of life (QOL) and health care utilization for PLWH.
METHODS: Using longitudinal data from the Study of HIV Infection in the Etiology of Lung Disease 2009-2017, we studied the association between changes in lung function and both QOL and acute care events (emergency department visit or hospitalization). The Medical Outcomes Studies-HIV Questionnaire provided QOL domains. Multivariable regression models were performed with generalized estimating equations accounting for 1499 participants, 485 with HIV, contributing 10,825 spirometry visits.
RESULTS: Among PLWH, decreased FEV1 was associated with worse physical health for those with higher viral load [β: -1.66, 95% confidence interval (CI): -3.11 to -0.39] compared to those with viral suppression (β: -0.58, 95% CI: -1.06 to -0.162), even in those without airflow obstruction. Lower FEV1 was also associated with increased odds of both emergency department (odds ratio: 1.21, 95% CI: 1.09 to 1.34) and inpatient (odds ratio: 1.26, 95% CI: 1.12 to 1.42) hospitalizations for PLWH. Lung function was not associated with increased odds of acute care events for HIV-uninfected participants.
CONCLUSIONS: FEV1 declines represent an independent predictor of QOL and acute care events among PLWH. Although the generalizability of these results may be limited, because of the high-risk population included, findings suggest that care for PLWH should involve monitoring FEV1 over time, especially in those with poor virologic control, with emphasis on the development and implementation of interventions to mitigate lung function decline.

Entities:  

Mesh:

Year:  2020        PMID: 32931685      PMCID: PMC7494951          DOI: 10.1097/QAI.0000000000002431

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.771


  36 in total

1.  Decreased Lung Function and All-Cause Mortality in HIV-infected Individuals.

Authors:  Matthew R Gingo; Mehdi Nouraie; Cathy J Kessinger; Ruth M Greenblatt; Laurence Huang; Eric C Kleerup; Lawrence Kingsley; Deborah K McMahon; Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2018-02

2.  Reduced Forced Vital Capacity Among Human Immunodeficiency Virus-Infected Middle-Aged Individuals.

Authors:  Sebastiaan O Verboeket; Ferdinand W Wit; Greg D Kirk; M Bradley Drummond; Reindert P van Steenwijk; Rosan A van Zoest; Jeannine F Nellen; Maarten F Schim van der Loeff; Peter Reiss
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

3.  Comorbidities in Persons With HIV: The Lingering Challenge.

Authors:  Andrea M Lerner; Robert W Eisinger; Anthony S Fauci
Journal:  JAMA       Date:  2020-01-07       Impact factor: 56.272

4.  Changes in the normal maximal expiratory flow-volume curve with growth and aging.

Authors:  R J Knudson; M D Lebowitz; C J Holberg; B Burrows
Journal:  Am Rev Respir Dis       Date:  1983-06

5.  A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (LIBERATE).

Authors:  Gerard J Criner; Richard Sue; Shawn Wright; Mark Dransfield; Hiram Rivas-Perez; Tanya Wiese; Frank C Sciurba; Pallav L Shah; Momen M Wahidi; Hugo Goulart de Oliveira; Brian Morrissey; Paulo F G Cardoso; Steven Hays; Adnan Majid; Nicholas Pastis; Lisa Kopas; Mark Vollenweider; P Michael McFadden; Michael Machuzak; David W Hsia; Arthur Sung; Nabil Jarad; Malgorzata Kornaszewska; Stephen Hazelrigg; Ganesh Krishna; Brian Armstrong; Narinder S Shargill; Dirk-Jan Slebos
Journal:  Am J Respir Crit Care Med       Date:  2018-11-01       Impact factor: 21.405

6.  Multi-ethnic reference values for spirometry for the 3-95-yr age range: the global lung function 2012 equations.

Authors:  Philip H Quanjer; Sanja Stanojevic; Tim J Cole; Xaver Baur; Graham L Hall; Bruce H Culver; Paul L Enright; John L Hankinson; Mary S M Ip; Jinping Zheng; Janet Stocks
Journal:  Eur Respir J       Date:  2012-06-27       Impact factor: 16.671

7.  Contributions of traditional and HIV-related risk factors on non-AIDS-defining cancer, myocardial infarction, and end-stage liver and renal diseases in adults with HIV in the USA and Canada: a collaboration of cohort studies.

Authors:  Keri N Althoff; Kelly A Gebo; Richard D Moore; Cynthia M Boyd; Amy C Justice; Cherise Wong; Gregory M Lucas; Marina B Klein; Mari M Kitahata; Heidi Crane; Michael J Silverberg; M John Gill; William Christopher Mathews; Robert Dubrow; Michael A Horberg; Charles S Rabkin; Daniel B Klein; Vincent Lo Re; Timothy R Sterling; Fidel A Desir; Kenneth Lichtenstein; James Willig; Anita R Rachlis; Gregory D Kirk; Kathryn Anastos; Frank J Palella; Jennifer E Thorne; Joseph Eron; Lisa P Jacobson; Sonia Napravnik; Chad Achenbach; Angel M Mayor; Pragna Patel; Kate Buchacz; Yuezhou Jing; Stephen J Gange
Journal:  Lancet HIV       Date:  2019-01-22       Impact factor: 12.767

8.  Relationship between lung function impairment and health-related quality of life in COPD and interstitial lung disease.

Authors:  Cristine E Berry; M Bradley Drummond; MeiLan K Han; Daner Li; Cathy Fuller; Andrew H Limper; Fernando J Martinez; Marvin I Schwarz; Frank C Sciurba; Robert A Wise
Journal:  Chest       Date:  2012-09       Impact factor: 9.410

9.  Association between Household Air Pollution Exposure and Chronic Obstructive Pulmonary Disease Outcomes in 13 Low- and Middle-Income Country Settings.

Authors:  Trishul Siddharthan; Matthew R Grigsby; Dina Goodman; Muhammad Chowdhury; Adolfo Rubinstein; Vilma Irazola; Laura Gutierrez; J Jaime Miranda; Antonio Bernabe-Ortiz; Dewan Alam; Bruce Kirenga; Rupert Jones; Frederick van Gemert; Robert A Wise; William Checkley
Journal:  Am J Respir Crit Care Med       Date:  2018-03-01       Impact factor: 30.528

10.  Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene.

Authors:  Emily S Wan; Peter J Castaldi; Michael H Cho; John E Hokanson; Elizabeth A Regan; Barry J Make; Terri H Beaty; MeiLan K Han; Jeffrey L Curtis; Douglas Curran-Everett; David A Lynch; Dawn L DeMeo; James D Crapo; Edwin K Silverman
Journal:  Respir Res       Date:  2014-08-06
View more
  1 in total

1.  Brief Report: HIV Is Associated With Impaired Pulmonary Diffusing Capacity Independent of Emphysema.

Authors:  Sarath Raju; Jacquie Astemborski; Michael Bradley Drummond; Hema C Ramamurthi; Jing Sun; Robert H Brown; Gregory D Kirk; Meredith C McCormack
Journal:  J Acquir Immune Defic Syndr       Date:  2022-01-01       Impact factor: 3.771

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.